TGFBR1 and colon adenocarcinoma: Importantly, pre-treatment of MSC with ALK5 inhibitor, the TGF-β1 type I receptor inhibitor, abolished the effects of stromal pre-conditioning with macrophages on colon adenocarcinoma cell growth (Fig. 6B-C, Supplementary Fig. 9).